At higher doses, the attention-deficit/hyperactivity disorder (ADHD) drug lisdexamfetamine dimesylate (Vyvanse) curtails the excessive food consumption that characterizes binge-eating disorder, preliminary research suggests. The findings were reported online Jan. 14 in JAMA Psychiatry.
Taking medication for attention-deficit/hyperactivity disorder might reduce the risk of young patients accidentally injuring themselves, new research suggests. The findings, published online Dec. 15 in Pediatrics, applied to both girls and boys.
Two generic versions of the attention-deficit/hyperactivity disorder drug Concerta may not work as effectively as the brand-name product does, the US Food and Drug Administration said Thursday.
The brains of children and adolescents with attention deficit hyperactivity disorder (ADHD) are slower to develop some key connections, according to a study published in the Proceedings of the National Academy of Sciences.
Otezla (apremilast) is an oral, selective phosphodiesterase 4 (PDE4) inhibitor for the treatment of patients with moderate to severe plaque psoriasis for whom phototherapy or systemic therapy is appropriate.
Adding an antipsychotic medication, such as risperidone, to stimulant therapy and parent training may improve parent ratings for behavioral problems in children with attention-deficit/hyperactivity disorder, according to research published in the September issue of the Journal of the American Academy of Child & Adolescent Psychiatry.